CF’s Q2 2026 Results Show Resilient Nitrogen Margins but Leadership Change Raises Questions

What happened

CF Industries posted Q2 2026 earnings in line with a gradually normalizing nitrogen market, with average selling prices dipping modestly from year-ago levels but gas costs remaining low, preserving healthy margins. Management emphasized progress on the Donaldsonville CCS project and reaffirmed Blue Point’s 2029 timeline, though capital outlays are ramping. However, the departure of the CFO, announced in January, hung over the call, as investors questioned whether the new interim CFO might alter the aggressive buyback strategy. Free cash flow remained robust but was partly diverted to growth projects, limiting upside for shareholder returns. Overall, the quarter reflects stability but amplifies our concerns about capital allocation discipline as the cycle matures.

Implication

Over the next 6-12 months, CF’s earnings face headwinds from potential nitrogen price normalization and gas spread compression, while elevated capex for low-carbon projects and a now-untested CFO could pressure capital returns. The WAIT rating stands: the risk-reward is balanced, but investors should monitor 2026 planting-season demand and CCS execution for signs of sustained EBITDA above $2.0B before adding.

Thesis delta

No material change to our underlying investment thesis. The Q2 results confirm our expectation of mid-cycle nitrogen earnings, but the CFO transition introduces modest governance risk. We maintain our $85 base-case valuation and WAIT rating, seeking a wider margin of safety below $70.